Promega launches new Lumit assays
Life sciences firm Promega has launched new bioluminescent assays for researchers studying immunity and inflammation. Read More
Mission Bio builds on Tapestri Platform
Mission Bio has added new features to its Tapestri Platform aimed at supporting research in solid tumors. Read More
Curiox Biosystems closes $15M funding round
Curiox Biosystems has completed a $15 million series C financing round. Read More
NanoHarmonics acquires Avagen Pharma
Biodiagnostic device company NanoHarmonics has acquired Avagen Pharma, a global distributor of a product that utilizes an advanced drug delivery system to treat premature ejaculation. Read More
Merck receives positive opinion from EMA for Keytruda
Merck announced that it received a positive opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use recommending approval for pembrolizumab (Keytruda) for patients with microsatellite instability-high or mismatch repair deficient tumors in five different types of cancer. Read More
Fujifilm acquires Shenandoah Biotechnology
Fujifilm Irvine Scientific has acquired recombinant protein manufacturer Shenandoah Biotechnology in a deal aimed at broadening its capabilities to support life science research, discovery, and cell and gene therapy. Read More
FDA approves, expands indication of HIV treatment Cabenuva
Cabotegravir and rilpivirine (Cabenuva), an HIV treatment co-developed by ViiV Healthcare and Janssen, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV-1 in virologically suppressed adolescents who are 12 years of age or older. Read More
Critically ill infants may benefit from whole genome sequencing
Critically ill patients in the neonatal intensive care unit could benefit from rapid whole genome sequencing, and its use could reduce disparities in access to testing, according to research presented at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting. Read More
Ichnos Sciences to present at AACR
Biotechnology company Ichnos Sciences will present preclinical data for ISB 1442, a bispecific antibody, at the American Association for Cancer Research (AACR) annual meeting, held April 8-13, 2022. Read More
NanoTemper launches Spectral Shift Technology
NanoTemper Technologies has launched Spectral Shift technology within their Dianthus instrument, which the company said is built to handle the most challenging affinity-based screenings in drug discovery. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
